Header Logo

Connection

NORMAN SUSSMAN to Humans

Back to Details
This is a "connection" page, showing publications NORMAN SUSSMAN has written about Humans.
NORMAN SUSSMAN
Connection Strength
0.418
Humans
  1. The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials. Hepatol Commun. 2025 May 01; 9(5).
    View in: PubMed
    Score: 0.026
  2. Drug-Induced Liver Injury in the Setting of Analgesic Use. Clin Liver Dis. 2020 02; 24(1):121-129.
    View in: PubMed
    Score: 0.018
  3. Alcohol and Alcoholic Liver Disease. Clin Liver Dis. 2019 02; 23(1):xiii-xiv.
    View in: PubMed
    Score: 0.017
  4. Extracorporeal Liver Support in Patients with Acute Liver Failure. Tex Heart Inst J. 2019 02; 46(1):67-68.
    View in: PubMed
    Score: 0.017
  5. Universal Screening for Hepatitis C: An Important Step in Virus Elimination. Clin Gastroenterol Hepatol. 2019 04; 17(5):835-837.
    View in: PubMed
    Score: 0.017
  6. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018 05; 24(5):711.
    View in: PubMed
    Score: 0.016
  7. The Headache of Acetaminophen Overdose: Getting the NAC. Clin Gastroenterol Hepatol. 2017 04; 15(4):563-564.
    View in: PubMed
    Score: 0.015
  8. Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation. Liver Transpl. 2016 Mar; 22(3):279-80.
    View in: PubMed
    Score: 0.014
  9. Treatment of Overt Hepatic Encephalopathy. Clin Liver Dis. 2015 Aug; 19(3):551-63.
    View in: PubMed
    Score: 0.013
  10. Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep. 2015 Apr; 17(4):17.
    View in: PubMed
    Score: 0.013
  11. Artificial liver. Clin Gastroenterol Hepatol. 2014 Sep; 12(9):1439-42.
    View in: PubMed
    Score: 0.012
  12. Long-term follow-up of portopulmonary hypertension patients after liver transplantation. Liver Transpl. 2014 Jun; 20(6):724-7.
    View in: PubMed
    Score: 0.012
  13. The end of hepatitis C. Clin Gastroenterol Hepatol. 2014 Apr; 12(4):533-6.
    View in: PubMed
    Score: 0.012
  14. Portopulmonary hypertension: an update. Liver Transpl. 2012 Aug; 18(8):881-91.
    View in: PubMed
    Score: 0.011
  15. Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death. Hepatology. 2012 Aug; 56(2):727-34.
    View in: PubMed
    Score: 0.011
  16. Pulmonary complications in cirrhosis. Curr Opin Organ Transplant. 2011 Jun; 16(3):281-8.
    View in: PubMed
    Score: 0.010
  17. Recurrent liver failure in a 25-year-old female. Liver Transpl. 2010 Sep; 16(9):1049-53.
    View in: PubMed
    Score: 0.010
  18. Hepatic assist devices: will they ever be successful? Curr Gastroenterol Rep. 2009 Feb; 11(1):64-8.
    View in: PubMed
    Score: 0.009
  19. Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G. Acta Haematol. 2008; 120(3):168-73.
    View in: PubMed
    Score: 0.008
  20. Acute hepatic dysfunction with abdominal pain and ascites. MedGenMed. 2007 May 09; 9(2):31.
    View in: PubMed
    Score: 0.008
  21. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant. 2006 Sep; 6(9):2177-82.
    View in: PubMed
    Score: 0.007
  22. Jaundice in a traveler returning from India. MedGenMed. 2006 Feb 16; 8(1):48.
    View in: PubMed
    Score: 0.007
  23. Larsucosterol for the Treatment of Alcohol-Associated Hepatitis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400243.
    View in: PubMed
    Score: 0.006
  24. Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose. Dig Dis Sci. 2024 Oct; 69(10):3952-3961.
    View in: PubMed
    Score: 0.006
  25. Modelling in vitro hepatotoxicity using molecular interaction fields and SIMCA. J Mol Graph Model. 2004 Jul; 22(6):487-97.
    View in: PubMed
    Score: 0.006
  26. Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement. Nat Rev Gastroenterol Hepatol. 2024 Sep; 21(9):626-645.
    View in: PubMed
    Score: 0.006
  27. Indeterminate etiology of acute liver failure in North America: Less common, still grave prognosis. Clin Transplant. 2023 12; 37(12):e15128.
    View in: PubMed
    Score: 0.006
  28. Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America. Liver Transpl. 2023 06 01; 29(6):570-580.
    View in: PubMed
    Score: 0.006
  29. A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition. J Biomol Screen. 2000 Aug; 5(4):249-54.
    View in: PubMed
    Score: 0.005
  30. Financial Compensation For Hepatologists in Different Practice Settings. Hepatology. 2019 06; 69(6):2664-2671.
    View in: PubMed
    Score: 0.004
  31. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.004
  32. Project ECHO: The Specialist Will See You Now. Hepatology. 2018 12; 68(6):2066-2068.
    View in: PubMed
    Score: 0.004
  33. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.004
  34. Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality. Am J Gastroenterol. 2018 09; 113(9):1319.
    View in: PubMed
    Score: 0.004
  35. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.004
  36. Extracorporeal liver support: cell-based therapy for the failing liver. Am J Kidney Dis. 1997 Nov; 30(5 Suppl 4):S66-71.
    View in: PubMed
    Score: 0.004
  37. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 07; 101(7):1609-1615.
    View in: PubMed
    Score: 0.004
  38. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.004
  39. Artificial liver support. Clin Invest Med. 1996 Oct; 19(5):393-9.
    View in: PubMed
    Score: 0.004
  40. Treatment of hepatic failure--1996: current concepts and progress toward liver dialysis. Am J Kidney Dis. 1996 May; 27(5):605-21.
    View in: PubMed
    Score: 0.004
  41. Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment. Hepatol Int. 2016 Jul; 10(4):624-31.
    View in: PubMed
    Score: 0.004
  42. Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer. Hepatology. 1995 Mar; 21(3):879-82.
    View in: PubMed
    Score: 0.003
  43. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device. Am J Gastroenterol. 1994 Jul; 89(7):1077-82.
    View in: PubMed
    Score: 0.003
  44. Extracorporeal liver support. Application to fulminant hepatic failure. J Clin Gastroenterol. 1994 Jun; 18(4):320-4.
    View in: PubMed
    Score: 0.003
  45. A treatment system for implementing an extracorporeal liver assist device. Artif Organs. 1994 May; 18(5):385-9.
    View in: PubMed
    Score: 0.003
  46. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. 1994 May; 18(5):390-6.
    View in: PubMed
    Score: 0.003
  47. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. ASAIO J. 1994 Jan-Mar; 40(1):83-5.
    View in: PubMed
    Score: 0.003
  48. Extracorporeal liver assist device (ELAD): a preliminary report. Transplant Proc. 1993 Aug; 25(4 Suppl 3):53-4.
    View in: PubMed
    Score: 0.003
  49. Mathematical modelling of chronic acetaminophen metabolism and liver injury. Math Med Biol. 2014 Sep; 31(3):302-17.
    View in: PubMed
    Score: 0.003
  50. Artificial liver: a forthcoming attraction. Hepatology. 1993 Jun; 17(6):1163-4.
    View in: PubMed
    Score: 0.003
  51. Extracorporeal liver assist in the treatment of fulminant hepatic failure. Blood Purif. 1993; 11(3):170-4.
    View in: PubMed
    Score: 0.003
  52. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs. 1993 Jan; 17(1):27-30.
    View in: PubMed
    Score: 0.003
  53. Liver assist devices (LADs) will not be used to treat fulminant hepatic failure (FHF), but its consequences, namely hepatic encephalopathy (HE) Artif Organs. 1993 Jan; 17(1):43-5.
    View in: PubMed
    Score: 0.003
  54. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology. 1992 Jul; 16(1):60-5.
    View in: PubMed
    Score: 0.003
  55. Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes. Am J Physiol. 1989 Jul; 257(1 Pt 1):G14-23.
    View in: PubMed
    Score: 0.002
  56. Treatment of hepatitis C infection. Gastroenterol Clin North Am. 2006 Jun; 35(2):463-86.
    View in: PubMed
    Score: 0.002
  57. Six-year perspectives on the safety and tolerability of nefazodone. J Clin Psychiatry. 2002; 63 Suppl 1:32-41.
    View in: PubMed
    Score: 0.001
  58. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996 Dec; 24(6):1446-51.
    View in: PubMed
    Score: 0.001
  59. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol Bull. 1991; 27(2):171-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.